§16§Contents: Introduction and Overview§Lymphopoietic Growth Factors: Pathophysiology of T-Cell§Mediated Shock Induced by Bacterial Superantigens - Natural§Killer Cells and Interleukin-2-Activated Killer Cells -§TumourImmunogenicity Induced by Exogenous Interleukins -§Cytokine Gene Therapy of Cancer - Analysis of T-Cell§Receptor Variability in Tumour Infiltrating Lymphocytes -§Clinical Studies with Interleukin-2: An Overview - Clinical§Trials with Local Administration of Lymphopoietic Growth§Factors - Clinical Trials with Interlaukin-2. The Rome§Experience.§Haematopoietic Growth Factors: Lymphohaematopoietic Growth§Factor Use in Lung Cancer Patients - Clinical Trials with§Haematopoietic Growth Factors and Peripheral Blood Stem§Cells §04§and Overview.- Lymphopoietic Growth Factors.- Pathophysiology of T-Cell Mediated Shock Induced by Bacterial Superantigens.- Natural Killer Cells and Interleukin-2-Activated Killer Cells.- Tumour Immunogenicity Induced by Exogenous Interleukins.- Cytokine Gene Therapy of Cancer.- Analysis of T-Cell Receptor Variability in Tumour Infiltrating Lymphocytes.- Clinical Studies with Interleukin-2: An Overview.- Clinical Trials with Local Administration of Lymphopoietic Growth Factors.- Clinical Trials with Interleukin-2. The Rome Experience.- Haematopoietic Growth Factors.- Lymphohaematopoietic Growth Factor Use in Lung Cancer Patients.- Clinical Trials with Haematopoietic Growth Factors and Peripheral Blood Stem Cells. §01§Prof. Dr. med. Roland Mertelsmann leitet als Ärztlicher Direktor die Abteilung Innere Medizin I, Hämatologie/Onkologie der Medizinischen Universitätsklinik und Poliklinik des Universitätsklinikums Freiburg.
